A.R.T. Advisors’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q3 | – | Sell |
-14,140
| Closed | -$26K | – | 70 |
|
2020
Q2 | $26K | Buy |
+14,140
| New | +$26K | 0.04% | 247 |
|
2020
Q1 | – | Sell |
-10,780
| Closed | -$30K | – | 37 |
|
2019
Q4 | $30K | Sell |
10,780
-10,894
| -50% | -$30.3K | ﹤0.01% | 1270 |
|
2019
Q3 | $33K | Sell |
21,674
-13,775
| -39% | -$21K | ﹤0.01% | 1345 |
|
2019
Q2 | $74K | Buy |
+35,449
| New | +$74K | ﹤0.01% | 1222 |
|
2019
Q1 | – | Sell |
-35,658
| Closed | -$137K | – | 1267 |
|
2018
Q4 | $137K | Sell |
35,658
-1,333
| -4% | -$5.12K | 0.01% | 1125 |
|
2018
Q3 | $349K | Buy |
+36,991
| New | +$349K | 0.02% | 986 |
|
2018
Q2 | – | Sell |
-14,491
| Closed | -$72K | – | 1373 |
|
2018
Q1 | $72K | Sell |
14,491
-38,991
| -73% | -$194K | ﹤0.01% | 1379 |
|
2017
Q4 | $270K | Buy |
53,482
+36,600
| +217% | +$185K | 0.01% | 1088 |
|
2017
Q3 | $104K | Buy |
+16,882
| New | +$104K | 0.01% | 1206 |
|
2015
Q4 | – | Sell |
-22,617
| Closed | -$137K | – | 1427 |
|
2015
Q3 | $137K | Buy |
+22,617
| New | +$137K | 0.01% | 1221 |
|
2014
Q4 | – | Sell |
-66,583
| Closed | -$1.41M | – | 1384 |
|
2014
Q3 | $1.41M | Buy |
+66,583
| New | +$1.41M | 0.07% | 409 |
|
2014
Q1 | – | Sell |
-26,832
| Closed | -$213K | – | 1296 |
|
2013
Q4 | $213K | Buy |
+26,832
| New | +$213K | 0.01% | 1097 |
|